Alessia Bari

8PUBLICATIONS
37CO-AUTHORS
Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma.

|Mar 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

|Dec 11, 2022
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.

Alessia Bari, Chiara Gerardi, Eleonora Allocati

|Feb 15, 2022
Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.

Luca Nassi, Vitaliana De Sanctis, Giacomo Loseto

|Oct 13, 2021
Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma.

Samantha Pozzi, Alessia Bari, Martin Pecherstorfer

|Jul 02, 2021
The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi.

Carla Minoia, Chiara Gerardi, Eleonora Allocati

Pageof 2

Frequent Collaborators

3 joint publications

Carla Minoia

1 joint publications

Raffaella Marcheselli

1 joint publications

Tamar Tadmor

1 joint publications

Stefano Sacchi